Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_provenance.
- NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_assertion description "[Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_provenance.
- NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_assertion evidence source_evidence_literature NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_provenance.
- NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_assertion SIO_000772 24877854 NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_provenance.
- NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_assertion wasDerivedFrom befree-20150227 NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_provenance.
- NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_assertion wasGeneratedBy ECO_0000203 NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP341631.RAvvXNvZ_Kkc3IHZQvHyg3TzeLjkCPaoXgItm-2a1OUrM130_provenance.